Mail

UK markets close in 1 hour 9 minutes

FTSE 100
8,213.58
-11.75(-0.14%)
FTSE 250
20,355.01
+56.91(+0.28%)
AIM
764.64
-1.28(-0.17%)
GBP/EUR
1.1812
-0.0005(-0.04%)
GBP/USD
1.2657
+0.0033(+0.26%)
Bitcoin GBP
49,215.48
+311.73(+0.64%)

Trending tickers

Amazon, Apple, Micron, Tesla

AI fever sets the tone for big tech stocks and chipmakers

Immunovia AB (publ) (IMMNOS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK

Add to watchlist

4.3450

-0.0950

(-2.14%)

As of 04:24PM BST. Market open.

Currency in SEK

Valuation measures⁴

Market cap (intra-day)	74.72M
Enterprise value	32.34M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	476.62
Price/book (mrq)	1.53
Enterprise value/revenue	502.36
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	2.60
52-week change ³	0.00%
S&P500 52-week change ³	24.60%
52-week high ³	18.5286
52-week low ³	4.3450
50-day moving average ³	18.5286
200-day moving average ³	18.5286

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	45.29M
Implied shares outstanding ⁶	45.29M
Float ⁸	38.22M
% held by insiders ¹	24.29%
% held by institutions ¹	1.93%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	-15,772.43%

Management effectiveness

Return on assets (ttm)	-104.98%
Return on equity (ttm)	-219.13%

Income statement

Revenue (ttm)	1.21M
Revenue per share (ttm)	0.03
Quarterly revenue growth (yoy)	-70.00%
Gross profit (ttm)	N/A
EBITDA	-148.56M
Net income avi to common (ttm)	-260.73M
Diluted EPS (ttm)	-6.0600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	51.18M
Total cash per share (mrq)	1.13
Total debt (mrq)	8.79M
Total debt/equity (mrq)	20.12%
Current ratio (mrq)	2.03
Book value per share (mrq)	0.96

Cash flow statement

Operating cash flow (ttm)	-131.59M
Levered free cash flow (ttm)	-34.06M